Diagnostics

Vijaya Diagnostic Centre soars 11% on heavy volumes in range bound market

India's diagnostic services market is expected to maintain double-digit growth (~12% CAGR) by FY30, driven by rising preventive healthcare awareness and expanding health insurance coverage.

Rising demand for GLP-1 weight-loss drugs reshaping diagnostics market

As GLP-1-based weight-loss and diabetes therapies gain popularity, India's diagnostics market is seeing a sharp rise in metabolic testing

Budget: Nathealth asks for ₹50k cr infra fund, tax SOPs for health checkups

Innovation fund for deep tech collabs, setting up of labs and 100% deduction on capex under section 35 AD of IT Act among key demands

Metropolis Q2 results: Profit up 13% on higher patient, test volumes

Metropolis Healthcare posted a 13% rise in Q2FY26 net profit to ₹53 crore, driven by increased patient and test volumes, network expansion, and improved performance across regions

Diagnostics labs find new growth vectors as health awareness rises

Green means trace amounts present. Yellow would indicate a moderate amount. Orange and red are danger indicators. My grandfather's insulin dose was titrated

Will Apollo, Max, Metropolis outshine peers in Q2? Here's what analysts say

Domestic brokerage firm Nuvama analysts forecast a modest sequential slowdown but a healthy ~17 per cent year-on-year (Y-o-Y) Ebitda growth, led by hospitals and diagnostics.

Delhi diagnostic players oppose genetic sample outflow ban order

Move was put in place after Delhi saw a fall in sex ratio at birth for 4th straight year, with officials fearing a return of prenatal gender testing

Prices of diagnostic tests unlikely to change much despite GST rate cut

GST reduction on medical devices, diagnostic kits, and reagents is a welcome move, but leading diagnostic players believe test prices will remain largely unaffected due to minimal changes

Metropolis Healthcare unperturbed by Amazon's diagnostics segment foray

'Amazon's entry is through a partnership with Orange Health. It is more of a distribution through Amazon'

Scientists develop AI system that can predict liver cancer recurrence

AI tool predicts liver cancer relapse with 82% accuracy, tackling a disease causing third-highest cancer-related deaths globally

Diagnostic firm Aarthi Scans eyes North India, lines up ₹350 cr investment

Chennai-based Aarthi Scans plans to add 65 new centres by 2030, with 90% in North India, while exploring fitness diagnostics and targeting a Rs 600 crore turnover

Genomic testing sees sharp uptake in India, now growing beyond metros

With 18 per cent CAGR, India's genomic diagnostics market is expanding into Tier 2 and 3 cities as affordability, cancer screening, and personalised care fuel adoption

Amazon enters at-home testing, launches diagnostics service in six Indian cities | Health sector

Amazon India has launched ‘Amazon Diagnostics’, its new at-home lab test service available via the Amazon app. Integrated into Amazon Medical along with its pharmacy and clinic verticals, the service

Amazon enters India's $15 bn diagnostics market with at-home testing

Amazon enters India's $15 bn diagnostics sector with at-home test collection, digital reports and integrated health services through Amazon Medical across six cities

Suraksha Diagnostics to invest ₹200 cr to set up 20 centres in east India

Suraksha Diagnostics on Wednesday said it will invest Rs 200 crore to set up over 20 advanced imaging centres across eastern India. The plan, which will be executed in collaboration with United Imaging, is aimed at expanding access to advanced diagnostic services in tier 2 and tier 3 cities, enhancing both affordability and healthcare quality in smaller towns and semi-urban regions, it said. No timeline was, however, revealed for the investment rollout. "This collaboration will assist us in expanding our reach and offer high-quality diagnostic services to a large population in eastern India," Suraksha Diagnostics CMD Somnath Chatterjee said. United Imaging will supply cutting-edge imaging solutions, while Suraksha Diagnostics will leverage its existing network and operational expertise to set up the new centres, the company said. Suraksha Diagnostics raised Rs 846.25 crore through an IPO in December for funding its expansion plans. At present, it operates 59 diagnostic centres an

Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

The company's revenue from operations also rose to Rs 603 crore in Q4FY25, a 10.5 per cent Y-o-Y growth from Rs 545 crore reported in Q4FY24

Dr Lal Path Labs Q4FY25 results: Net profit rises 83.2% to ₹155 crore

The company's consolidated net profit jumped 83.2 per cent year-on-year to Rs 1.55 billion (about $18 million) in the quarter ended March 31

This smallcap stock zooms 32% in 1 week, nears 52-week high. Do you own?

Share price of Thyrocare Technologies has moved higher by 11 per cent to ₹938.65 on the BSE in Friday's intra-day trade and recovered 13 per cent from its intra-day low of ₹830.90.

Metropolis Healthcare expands footprint in North with Dapic acquisition

With its third acquisition in recent times, Metropolis' Ameera Shah said the firm will make another deal this financial year

In India, 3 in 5 die following cancer diagnosis, women more affected: Study

Three in every five people in India succumb to cancer following diagnosis with women bearing a "disproportionate burden" compared to men, an analysis of global cancer data has estimated. The incidence to mortality ratio in the US was found to be about one in four, while in China it was one in two, according to the results published in 'The Lancet Regional Health Southeast Asia' journal. The Indian Council of Medical Research (ICMR) study found that India ranked third highest in cancer incidence, after China and the US, and accounted for over 10 per cent of the world's cancer-related deaths, ranking second after China. Researchers also projected that in the coming two decades, India will face a formidable challenge in managing deaths related to cancer incidence, with a yearly increase of two per cent in cases as the population ages. The team examined trends in 36 types of cancer across age groups and genders in India over the past 20 years, using the Global Cancer Observatory ...